A new series of lipocrine derivatives has been designed by replacing the antioxidant alfa lipoic residue with carbazole moiety of carvedilol.
Multitarget-directed drug design strategy: novel hybrid compounds between lipocrine and carvedilol / Rosini M; Simoni E; Bolognesi ML; Andrisano V; Bartolini M; Tarozzi a; Hrelia P; Mellor I; Melchiorre C.. - STAMPA. - (2007), pp. 83-83. (Intervento presentato al convegno 16th Camerino-Noordwijkrhout symposium "An overview of receptor chemistry tenutosi a Camerino nel September 9-13, 2007).
Multitarget-directed drug design strategy: novel hybrid compounds between lipocrine and carvedilol
ROSINI, MICHELA;SIMONI, ELENA;BOLOGNESI, MARIA LAURA;ANDRISANO, VINCENZA;BARTOLINI, MANUELA;TAROZZI, ANDREA;HRELIA, PATRIZIA;MELCHIORRE, CARLO
2007
Abstract
A new series of lipocrine derivatives has been designed by replacing the antioxidant alfa lipoic residue with carbazole moiety of carvedilol.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
